Dernière mise à jour :
Stabilité et compatibilité des médicaments
Bienvenue dans Stabilis.
Si vous désirez recevoir la newsletter trimestrielle, indiquez votre adresse email. Inscrivez-vous

Pour toute question ou remarque, contactez :
Base de données  
Références bibliographiques : 2704
Molécules : 836
Classes pharmacologiques : 46
Stabilités en solution : 6115
Stabilités en mélange : 1199
Compatibilités : 12068
Noms commerciaux : 4605
Nouveautés - Molécules  
Divers Gélule Fludrocortisone acetate 05/05/2022
Anti-démence Solution buvable Pimavanserin 05/05/2022
Anticancéreux Solution buvable Imatinib 03/05/2022
Anticancéreux Forme dermique Erlotinib 03/05/2022
Antifongique Forme dermique Voriconazole 03/05/2022
électrolyte Injectable Magnesium chloride 14/03/2022
Immunosuppresseur Injectable Adalimumab 06/03/2022
Hormone Forme dermique Gestrinone 04/03/2022
Antiinflammatoire Forme dermique Nimesulide 04/03/2022
Antiinflammatoire Forme dermique Piroxicam 04/03/2022
Divers Solution buvable Quetiapine fumarate 24/02/2022
Antiinflammatoire Sachet papier Hydrocortisone 24/02/2022
Antihypertenseur Sachet papier Clonidine hydrochloride 24/02/2022
Antalgique Forme dermique Morphine hydrochloride 24/02/2022
Antibiotique Solution buvable Co-trimoxazole 07/12/2021
Anticancéreux Injectable Isatuximab 01/12/2021
Divers Solution buvable Tizanidine hydrochloride 29/11/2021
Anxiolytique Suppositoires Diazepam 29/11/2021
Anesthésique général Solution buvable Ketamine hydrochloride 15/10/2021
Anticancéreux Injectable Pemetrexed disodium hemipentahydrate 27/09/2021
Nouveautés - Références bibliographiques  
Date de saisie
4686 Pertuzumab (Perjeta®) - Summary of Product Characteristics. Roche Products Ltd. 24/05/2022
4673 Physicochemical Stability of a Novel Tacrolimus Ophtalmic Formulation for the Treatment of Ophtalmic Inflammatory Diseases. Pharmaceutics 16/03/2022
4670 Stability and Formulation of Erlotinib in Skin Creams. Molecules 09/03/2022
4671 Voriconazole topical cream formulation: evidence for stability and antifungal activity. Int J Antimicrob Agents 09/03/2022
4665 LEMTRADA 12 mg concentrate for solution for infusion - Summary of Product Characteristics. Updated 24-Sep-2021 Sanofi Aventis 15/02/2022
4661 Stability of a high-concentrated aqueous solution of idarubicin stored in a polypropylene syringe for transarterial chemoembolization J Pharm Biomed Anal 05/02/2022
4655 Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration. Am J Health-Syst Pharm 25/01/2022
4653 Development of a sterile morphine hydrogel for the local treatment of painful skin ulcers. EJHP 24/01/2022
4654 Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables. Communication personnelle 24/01/2022
4652 Nivolumab (Opdivo®) - Summary of Product Characteristics Bristol Myers Squibb Pharmaceuticals 22/01/2022
4651 Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 18/01/2022
4650 Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 12/01/2022
4649 Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices. GaBI Journal 29/12/2021
4648 Stability evaluation of compounded clonidine hydrochloride oral liquids based on a solidphase extraction HPLC-UV method. PlosOne 16/12/2021
4646 Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates). Int J Pharm Compound 24/11/2021
4645 Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy. JAC Antimicrob Resist 17/11/2021
4643 Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes. EJHP 15/11/2021
4640 Stability of Ampicillin in Normal Saline Following Refrigerated Storage and 24-Hour Pump Recirculation. Hosp Pharm 08/11/2021
4641 Stability of high concentrated triple intrathecal therapy for pediatrics and mitigation strategies. Eur J Pharm Sci 08/11/2021
4638 Stability of Extemporaneously Compounded Suspensions of Trimethoprim and Sulfamethoxazole in Amber Plastic Bottles and Amber Plastic Syringes. Can J Hosp Pharm 03/11/2021
4639 Stability of N-Acetylcysteine 60 mg/mL in Extemporaneously Compounded Injectable Solutions. Can J Hosp Pharm 03/11/2021
4636 Design and stability of pediatric oral formulation of imatinib J Oncol Pharm Practice 26/10/2021
4637 Evaluation of physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets - a Hospital concern. Braz J Pharm Sci 26/10/2021
4635 Physicochemical stability of human insulin 1 I.U./mL infusion solution in 50 mL polypropylene syringes. Pharmaceutical Technology in Hospital Pharmacy 04/10/2021
4634 Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics 30/09/2021
4630 Stability of clonidine hydrochloride in an oral powder form compounded for pediatric patients in Japan. J Pharm Health Care Sci 29/09/2021
4633 Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures. Pharmaceutics 29/09/2021
4629 Pemetrexed Sandoz - Summary of Product Characteristics (SmPc) 27/09/2021
4628 Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations. Pharmaceuticals 24/09/2021
4627 Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature. Adv Ther 21/09/2021

  Mentions Légales